Mahyar Khazaeli
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Gut microbiota and health, Iron Metabolism and Disorders, Genomics, phytochemicals, and oxidative stress, Glutathione Transferases and Polymorphisms, Diet and metabolism studies
Most-Cited Works
- → Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats(2016)302 cited
- → High Amylose Resistant Starch Diet Ameliorates Oxidative Stress, Inflammation, and Progression of Chronic Kidney Disease(2014)276 cited
- → Lipidomics Biomarkers of Diet-Induced Hyperlipidemia and Its Treatment with Poria cocos(2016)113 cited
- → Oral Activated Charcoal Adsorbent (AST-120) Ameliorates Chronic Kidney Disease-Induced Intestinal Epithelial Barrier Disruption(2013)100 cited
- LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.(2017)
- → LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis, and Vasculopathy in a Rat Model of Chronic Kidney Disease(2018)91 cited
- → Role of Nrf2 Dysfunction in Uremia-Associated Intestinal Inflammation and Epithelial Barrier Disruption(2014)89 cited
- → The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease(2013)78 cited
- → The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease(2013)47 cited
- → Dose-dependent deleterious and salutary actions of the Nrf2 inducer dh404 in chronic kidney disease(2015)44 cited